Replies to post #3367 on ImClone Systems Inc (formerly IMCL)

[bio_guyo]

Looks to me like the trial is an academic one, and that both Roche and eMerck have agreed to supply drug.

It's about time the head-to-head comparisons were done between Erbitux and Avastin in first-line CRC. The main drawback I see is that it's a relatively small phase II study that is unlikely to provide conclusive data.